Title : Navigational bronchoscopy: Present capabilities and future promise
Abstract:
Navigational bronchoscopy represents a paradigm shift in the diagnosis and management of peripheral pulmonary lesions. This minimally invasive technology guides endoscopic tools to pulmonary lesions with unprecedented precision, addressing a critical clinical need in contemporary pulmonary medicine. The increasing detection of pulmonary nodules through lung cancer screening programs and incidental findings on cardiac and abdominal CT scans has created significant diagnostic challenges. Over 90% of nodules identified in the National Lung Cancer Screening trial were benign, necessitating accurate yet minimally invasive characterization methods to reduce patient morbidity. Navigational bronchoscopy demonstrates significantly higher diagnostic yields compared to conventional bronchoscopy, with multi-center studies reporting 12-month diagnostic yields of 73% and procedural completion rates of 94%. Two primary technological approaches have emerged: Electromagnetic Navigation Bronchoscopy (ENB) and Virtual Bronchoscopic Navigation (VBN). ENB platforms, including the SuperDimension™ system and SPiN Thoracic Navigation System™, generate electromagnetic fields around the patient enabling real-time sensor tracking mapped to 3D CT reconstructions. VBN platforms such as LUNGVISION™ and Archimedes™ utilize augmented fluoroscopy and bronchoscopic transparenchymal nodule access procedures. Recent advances in robotic bronchoscopy have further enhanced capabilities. The Ion™ endoluminal system employs shape-sensing catheters with cone-beam CT integration, achieving diagnostic yields up to 85.9%. The Monarch™ platform utilizes dual-scope electromagnetic navigation with continuous endoscopic visualization. The Galaxy system integrates digital tomosynthesis (TiLT+) for real-time tool-in-lesion confirmation, reporting diagnostic yields of 89.5% with 100% target localization in early trials. Future developments include artificial intelligence integration with automated airway segmentation (NaviAirway model), autonomous co-pilot systems with AI-human shared control algorithms, and therapeutic expansion encompassing transbronchial microwave ablation, near-infrared fluorescence imaging, and autofluorescence imaging for tissue characterization. Navigational bronchoscopy continues to evolve as an essential tool in interventional pulmonology, offering enhanced diagnostic accuracy, reduced complications, and expanding therapeutic applications for peripheral lung lesions.
